Clinical trial
Value of the Perfusion Index in Predicting the Severity of Diabetic Ketoacidosis in the Emergency Department and Evaluation of Its Combination With Lactate: A Prospective Cohort Study
NCT07820371 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Value of the Perfusion Index in Predicting the Severity of Diabetic Ketoacidosis in the Emergency Department and Evaluation of Its Combination With Lactate: A Prospective Cohort Study
- Lead sponsor
- Ankara Etlik City Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 15, 2026
- Completion date
- April 30, 2027
- Enrollment
- 140 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.